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ABSTRACT
Background: Breast carcinoma recurrence appears in 5%–30% of cases, after the completion of breast 
cancer treatment. Recurrence appears on thoracic wall (chest wall), on the skin, on the breast tissue 
remaining after the surgery, equal sided axillary lymph nodes, supraclavicular lymph nodes or on the 
internal mammary lymph nodes. Recurrence often stays undetected by clinical examination, while it 
can be detected by ultrasound and punctured under ultrasound control.  Cytological confirmation of 
malignant cells represents a signal to commence a specific recurrence treatment. 
Methods:Aspiration puncture under ultrasound control has been performed within 128 patients. Only 38 patients, 
out of 128, did not have distant metastasis at the moment of recurrence detection, so the recurrence was sur-
gically removed and was subjected to the histopathological analysis. The results of definite histopathological 
analysis were compared to the clinical results and cytological results, which had been obtained preoperatively.
Results: 31 patients, out of above mentioned 38 patients, have had breast carcinoma recurrence, while 
7 patients have had benign tumor lesion. Clinical diagnoses were correct in 47.4% of cases, and incor-
rect for 52.6%. False positive finding result happened in 7.89% cases and false negative finding result 
happened in 39.47% cases. Ultrasound diagnoses were correct for 86.84% of patients and incorrect for 
13.16% of patients. Cytological analysis of material obtained by aspiration puncture under ultrasound 
control produced correct diagnoses for 86.84% of patients. 13.16% of patients had inconsistent cyto-
logical and histopathological findings result. Cytological analysis has detected malignant cells for 5.26%, 
but the recurrence was not histopathologically confirmed, which points that the results were falsely 
positive. Falsely negative results were confirmed for 7.89%.  
Conclusion: Clinical examination was reliable for 52.6% of patients examined. Cytological analysis of 
material obtained by ultrasound-controlled puncture was reliable for 86.84% of patients examined. 
Aspiration puncture followed by cytological analysis gave falsely negative result for 7.89% of patients 
examined, while clinical examination gave falsely negative result for 39.47% of patients examined. 
Aspiration puncture gave falsely positive result for 5.26%, and clinical examination gave falsely positive 
result for 7.89%.  Aspiration puncture is simple, easy to perform, without damaging effect for the patient 
or the medical personnel, it is not expensive and it is significantly more reliable than clinical examination 
itself for detection of breast carcinoma recurrence.
  
Keywords:Breast Neoplasms; Neoplasm Recurrence, Local; Diagnosis; Biopsy, Needle; Ultrasonography; 
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INTRODUCTION
T
he breast carcinoma is the most frequent malignant disease within female population, 
which, in spite of performed treatment, often appears as recurrence or metastasis (1). 
This is the reason why control examination on regular basis is recommended (2). This 
term refers to a tumor in thoracic wall (chest wall), skin of that area, on surgically spared 
breast, on equal sided axillary lymph nodes, on supraclavicular nodes or internal mammary 
nodes (3). Risk from recurrence manifestation depends on tumor penetration range on 
axillary group of lymph nodes, tumor size when first diagnosed, as well as it depends on 
receptive status, tumor grade, angioinvasion etc. Loco-regional recurrence manifestation 
rate varies from 5% to 30% (4). 60%-80% of recurrences appear within first two years after 
mastectomy. It rarely appears after 5 or more years (5). Clinically suspicious tumor lesion 
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Approximately 25% of patients will develop metastasis soon after appearance of recur-
rence. Such recurrence is not necessary a signal for upcoming systematic disease (7). 
Approximately 5% to 15% of patients treated with lumpectomy and radiation, will develop 
some type of recurrence during the control period (8). Mammography and clinical examina-
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tion are used for detection of recurrence in breasts after surgery (9).  However, due to the 
development of improved ultrasound devices, this method has taken leading role in obser-
vation of such patients, together with puncture followed by cytological analysis (10,11). 
The techniques for performing ultrasound controlled aspiration puncture can vary from 
author to author and institution to institution.(12). Today ultrasound is the only acceptable 
method for evaluation and examination of thoracic wall after mastectomy. Approximately 
80% of palpable lesions can be defined as benign or malignant in those cases, while simple 
palpation method can do the same in approximately 36% of cases (13). The ultrasound is 
useful to evaluate the depth of infiltration, the relation of lesion to surrounding structures, 
and it is especially useful when observing and controlling those patients, that were subjects 
to surgical intervention and radiation of remaining breast tissue (14). A simple way for 
obtaining recurrence confirmation is ultrasound controlled aspiration puncture (fine needle 
aspiration-FNA), that has 90% diagnostic accuracy, and 1% of falsely positive and 15% 
of falsely negative results (15). The sensitivity of fine-needle aspiration, according to the 
literature, goes up to 95.33%, and its specific rate goes up to 99.22% (16). Different results 
can be found in literature regarding fine-needle aspiration cytology. For example, sensitivity 
rates from 65.4% to 99%, while specific rate goes from 96% to 100% (17). If the material 
is examined macroscopically and microscopically by experienced pathologist, the accurate 
diagnosis can be expected for 98% of tumors. False negative result is always possible due 
to the limiting factors of diagnosing (18). Appropriate procedure for obtaining material, 
its dispatch to the laboratory, as well as way of material processing have great effect on 
interpretation, whether it will be correct or not. Impressive results are given by institutions, 
which have well trained radiologists and, above all, cytologists (19). Sometimes it is suf-
ficient to determine existence of malignant disease (for example disease recurrence), if 
it is not possible to determinate histological form (20). Because of increased interest in 
cytology breast puncture it is necessary to uniform indication criteria (21). Also the matter 
of damaging factors of cytodiagnostic breast puncture is often addressed. By observing 
overall survival and disease recurrence with patients who have been subjected to puncture 
and with control group, there was neither found difference regarding 5 year survival, nor 
regarding recurrence appearance. This confirms statement that cytological puncture is not 
damaging (22). 
Aims of the study were: to analyze and compare concordance of clinical examination 
results to the results of aspiration puncture followed by histopathological diagnoses 
(PHD) of breast carcinoma recurrence; to show that fine-needle aspiration is more 
accurate and reliable than clinical examination in recurrence detection, and to show that 
fine-needle aspiration followed by cytological analysis is irreplaceable diagnostic method 
in detection of breast carcinoma recurrence. 
PATIENTS AND METHODS
Study period was from January 2002 to August 2004. In this period, 128 patients were 
diagnosed with loco-regional recurrence of malignant breast disease. Some of the tumor 
lesions were palpable and clinically visible, and the other could not be clinically observed, 
so they had to be verified by ultrasound, during routine ultrasound examinations of post-
operative incision area and area of regional lymph nodes. The stated number of patients 
included 38 of those who were re-operated and had histopathologically (PHD) verified 
disease. The other 90 patients were treated by other modalities, chemotherapy (HT), 
DQGRUUDGLDWLRQEHFDXVHDWWKHPRPHQWRIUHFXUUHQFHGHWHFWLRQWKH\KDYHDOUHDG\KDG
distant metastasis. 
The ultrasound device that was used for examination is equipped with linear sound of 
5 and 7.5. The 3.5MHz sound was also used to confirm or exclude existence of distant 
metastasis (liver, etc). 
If pathological tumor lesions were found clinically or by ultrasound examination, they were 
exposed to puncture under ultrasound control, to provide assurance that the needle was in 
this very lesion and that sample was taken from adequate localization.
Technique of performing aspiration breast biopsy under ultrasound 
control 
This method can be performed by needle leader or by hand, without needle leader, as it was 
performed in our institution, as it is shown on scheme.
Figure 1. Ultrasound controlled puncture 
Fine-needle aspiration biopsy is performed in sterile local field conditions, which requires 
skin cleansing in area where puncture is to be performed. Sound cleansing is required also. 
After this, targeted lesion is shown by ultrasound. Needles of 0.7 x 65 mm or 0.9 x 90 mm 
are used for puncture. These needles are fixed to the syringe of 10 ccm or 20 ccm. The 
greater volume is better because it has stronger suppress. The puncture is performed under 
ultrasound control, following and directing the needle into the lesion. When it is certain that 
needle is in the lesion (which is monitored) syringe clip is pulled and by moving needle with 
syringe many times (10 – 20) into the lesion, backward and forward, the cytological analy-
sis material is obtained. Cytological analysis is done in Institute for Pathology of Clinical 
Centre Banja Luka by a pathologist-cytologist. Staining is done according to Giemsa, the 
material is analyzed, and results are brought in. 
The results of cytological analysis are compared with definite histopathological results of 
material obtained after the surgical removal of tumor lesion. This determines the percent-
age of accuracy of the method in practical use and its usage justification. Of course, being 
that it is analysis of the cytological material, the presence of malignant cells would be valid 
confirmation. The absence of malignant cells does not exclude the possibility of existence 
of malignant disease. The repetition of punctures is approved.
Data processing and presentation of results 
Results were processed as follows:
1. ,WZDVPDUNHGZKHWKHUWKHOHVLRQZDVGLDJQRVHGFOLQLFDOO\DQGRUE\XOWUDVRXQG
2. Ultrasound characteristics were marked as benign or malignant lesions 
3. All lesions are punctured under ultrasound control 
4. Obtained material was stained by May – Grďnwald – Giemsa method
5. Cytological analysis was marked with “present” or “absent” malignant cells
6. The results of cytological analysis of material obtained preoperatively  were compared 
to histopathological finding, obtained after surgical removal of lesion.
Obtained data were imported into PC database and processed. The results were present-
ed by diagrams, tables, and photos. As only absolute frequencies were given (number of 
patients), the only possible method to be used is C
2 test. Thus, Fisher method of exact 
probability of null hypothesis was used, that allows existence of null and frequencies lss 
valued than 5 in specific table cells.
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RESULTS
Distribution of clinical examination and PHD concordance
Out of total number of 38 patients, 19 had tumor lesion that were detected during the clinical 
examination by palpation. These lesions were found in thoracic wall, axilla or in the breast tissue 
that remained after surgery. The disease clinical diagnosis was set (positive clinical examina-
tion or finding). No palpable lesions were detected for other 19 patients in stated regions, so the 
breast carcinoma recurrence was not suspected to exist (negative clinical examination). 
Table 1. Distribution of concordance of clinical examination and PHD
Clinical
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Number of clinical findings in relation to PHD
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PHD-pathohistological diagnoses
Out of 19 palpable lesions, 16 were detected to be tumor recurrence indeed, which was con-
firmed histopathologically. For 3 patients, that were clinically suspected to have disease recur-
rence, recurrence was not confirmed, but benign lesions (Table 1). Out of 19 patients that did 
not have palpable recurrence, 15 had malignant disease confirmed, and 4 were confirmed not 
to have disease recurrence. In table 1, it is evident that in 42.11% cases the clinical diagnosis 
was correlated to definite PHD finding result. It is evident that the recurrence was confirmed 
by histopathological method after the surgical removal of tumor in 42.11% of cases. 
In table 1, it is evident that correlation and concordance of clinical examination with PHD 
finding results for exclusion of tumor recurrence, was in 10.53% of cases. 
Once these results are put together, we get that clinical examination in detection of tumor 
recurrence was reliable in 52.64% of cases. It is evident that in 7.89% of cases that were 
suspected to have disease recurrence after the clinical examination, the recurrence was 
not confirmed by PHD. It can be said that clinical examination had false positive results 
in 7.89% of cases.
In table 1 it is evident that in 39.47% of cases that were not suspected to have disease 
recurrence after the clinical examination, the recurrence was confirmed by PHD after the 
extirpation, meaning that 39.47% of cases had false negative clinical results.   
Distribution of FNAC and PHD concordance 
In order to achieve higher accuracy of lesions etiology evaluation that were clinically 
detected and those confirmed by ultrasound, one step further is being taken and lesions 
are punctured under ultrasound control, after which the cytological analyses of mate-
rial is done (FNAC-fine-needle aspiration citology). If in the obtained material malignant 
breast carcinoma cells are detected, the results are declared positive, meaning that it is 
local breast carcinoma recurrence. If the malignant cells are not detected, the results are 
declared negative.
Out of 38 patients that had been put through fine needle aspiration and cytological analysis 
of material (FNAC), 30 patients had malignant cells detected, which had confirmed breast 
carcinoma recurrence.
Analyzing concordance of positive cytological result for 30 patients, with definite histopatho-
logical results, we have found that for 28 patients, or 73.68%, the results were in concordance 
with each other. For 2 patients, or 5.26%, the cytological result was not in concordance with 
histopathological result, thus those were the cases of false positive results (Table 2). 
Table 2. Distribution of concordance of Ultrasound – FNA finding and PHD
Ultrasound
- FNAC
Number of ultrasound – FNAC finding in relation to PHD
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FNAC- fine-needle aspiration citology  fine-needle aspiration citology
PHD-pathohistological diagnoses
In table 2 it is evident that for 8 patients, or 21.05%, there were no malignant cells detected 
by cytological analysis. However, in definite histopathological material for 5 patients 
(13.16%) there was no disease recurrence found, indeed. While for 3 patients, (7.89%) the 
recurrence was confirmed. Those were the cases of false negative FNAC (Table 1).
Concordance of results of FNAC and PHD, the method accuracy rates for recurrence confir-
mation (73.68%), as well as for recurrence exclusion (13.16%) in total of 86.84%.
DISCUSSION
According to the literature data, local disease recurrence most commonly appears 
within first two years after mastectomy, and appearance rate varies from 5% to 30% (5,6). 
European Oncologists’ Association recommends regular control in order to detect tumor 
UHFXUUHQFHDVHDUO\DVSRVVLEOHDQGLWDOVRUHTXLUHVF\WRORJLFDODQGRUKLVWRSDWKRORJL-
cal confirmation of recurrence whenever possible (2). Those were the reasons why our 
Institution has developed regular usage of fine-needle aspiration of suspected lesions, 
followed by cytological analysis of material.  
The fact itself that 52.6% patients have had clinically detected recurrence, requires further   
clinical testing in order to detect recurrence at early stage. It is possible to define the 
detected lesion as malignant or benign by palpation in 36%  cases. The ultrasound, is 
exceptionally useful, not only in lesion detection, but also in evaluation of infiltration depth, 
relation of lesion to the surrounding structures, as well as in observation and control of 
those patients that have already been treated by surgery and radiation (14).
At first it is important to palpate the lesion as small dimension as possible. When the region 
that has already been radiated is in question (and it is known that those cases can develop 
tumor recurrence in 10% of cases (2), it is rather difficult to palpate the lesion of few mil-
limeters to 1 cm in range, if there is a lot of fibrous tissue. In case that there is lymph node in 
between ribs, next to sternum, it is necessary that it has greater diameter in order to come out 
of rib line, so that it would be possible to palpate it. In order to palpate node located highly in 
the axilla, or under frontal axillar crease, between two pectoral muscles, or in subclavian region 
in space between clavicle and ribs, it is necessary that it has larger dimensions. Approximately 
70% of all breast tumors are clinically palpable, and tumors smaller than 0.6cm to 1 cm are 
palpable in approximately 50% of cases (23). They also state that success depends on many 
conditions such as age, breast size, whether the radiation has been previously undertaken 
or not, depth of recurrence location, etc. On the other side, node of granuloma type often 
deceives medical experts and they can suspect it to be a recurrence. The same situation was 
in our case of 7.89% of false positive results, while 39.47% were false negative results (15).   
It has already been mentioned that many literature sources state the rate of 36% of cases in 
which it is possible to define clinical lesion as malignant or benign (13). 
If the lesion is removed because it was suspected to be a recurrence, and this has not been 
confirmed histopathologically, further treatment in terms of radiation or systemic chemo-
therapy will not be required. The problem would occur if systemic treatment was started 
prior to confirmation of histopathological or cytological finding of recurrence.
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Analysis of concordance of aspiration puncture and cytological 
analysis to PHD
Correlation between cytological and histopathological results is obtained in 86.84% cases. 
The rate of false positive results was 5.26%, and false negative results 7.89%. Literature 
sources state the rate of 0.1% to 2.5% for false positive, and 0% to35% for false negative 
results (15,16). Literature sources states that 90% accuracy of FNAC has 1% of false 
positive and 15% of false negative results (18). Specific rate goes even up to 99.22% (16). 
Even different results can be observed through literature for the accuracy of fine-needle 
aspiration cytology. For example, sensitivity rates from 53% to 99%, and specific rate goes 
from 96 to 100% (17). 
Proper way of material obtaining, material laboratory dispatch, and the way of material 
is being processed has great influence on correct interpretation (18). Once all of this is 
overviewed, it is possible to explain why recurrence was finally confirmed after negative 
cytological finding for 3 patients. Material obtain is first in question. When it was analyzed 
which of the patients had negative finding, it was observed that those were the patients 
that had puncture done at the beginning of practice of this technique at the Institution, and 
at that time experience of performer was not as good as it is now. In time, the method of 
deposit, drying and transport of obtained material was agreed with Institute of Pathology. 
The experience of cytopathologist in malignant cells diagnoses has important role. If neo-
plasm is macroscopically and microscopically examined by pathologist that is experienced 
in this area, the accurate diagnoses can be expected in 98% of tumors. False negative result 
is always possible due to the limiting factors of diagnosing (18).  Solving the problem of 
existence of malignancy is the basis of cytodiagnostics of breast carcinoma recurrence, 
since we already have histopathologically diagnosed disease (20). This is done in order 
to commence the treatment if necessary, as soon as possible. Good cooperation with 
surgeon, who extirpates the cytologically verified recurrence, also is very important. 
In one case (out of 3 false negative cases) the surgeon has removed the lesion that was 
not punctured, meaning that the wrong lesion was extirpated, and the lesion that was 
recurrence in certain remained in patient’s body. This patient was directed to surgery again, 
when the correct lesion was extirpated and confirmed by histopathological finding. This 
result was filed within positive results when specific method calculation was done. In other 
cases it is most probable that disintegrated, degenerative cells deceived cytopathologist 
who marked them malignant even though they were not malignant. Impressive results are 
given by institutions that have well trained radiologists, and above all well trained cytolo-
gists (11,24).
CONCLUSION
• Clinical examination has shown accuracy for 52.64%, and FNAC for 86.84%.
x  Ultrasound controlled aspiration puncture with cytological sample analysis of palpable 
and impalpable lesion, showed to be efficient in early detection of repeated appearance 
of disease after breast carcinoma surgery.
x  It is quick and minimally invasive diagnostic method. It is simple, easily performed, 
requiring minimum of staff and training, it is not damaging for staff or patient, it is 
efficient and not expensive method.
x   FNAC is very valuable and exact method, but there is still work to be done until the 
results can correlate to those in literature.
x Significance of fine-needle aspiration, its cytological analysis and aspiration of 
obtained material, is in early detection of recurrence and commencement of adequate 
treatment.
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